These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25773729)

  • 1. Penalized regression for interval-censored times of disease progression: Selection of HLA markers in psoriatic arthritis.
    Wu Y; Cook RJ
    Biometrics; 2015 Sep; 71(3):782-91. PubMed ID: 25773729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable selection and prediction in biased samples with censored outcomes.
    Wu Y; Cook RJ
    Lifetime Data Anal; 2018 Jan; 24(1):72-93. PubMed ID: 28215038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-phase model for chronic disease processes under intermittent inspection.
    Wu Y; Cook RJ
    Stat Med; 2017 Jun; 36(13):2016-2031. PubMed ID: 28238209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of interval-censored recurrent event processes subject to resolution.
    Shen H; Cook RJ
    Biom J; 2015 Sep; 57(5):725-42. PubMed ID: 26148993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway.
    Nossent JC; Gran JT
    Scand J Rheumatol; 2009; 38(4):251-5. PubMed ID: 19247847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker development in psoriatic arthritis.
    Ritchlin C
    J Rheumatol Suppl; 2012 Jul; 89():57-60. PubMed ID: 22751594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease manifestations and HLA antigens in psoriatic arthritis in northern Sweden.
    Alenius GM; Jidell E; Nordmark L; Rantapää Dahlqvist S
    Clin Rheumatol; 2002 Sep; 21(5):357-62. PubMed ID: 12223981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of psoriatic arthritis.
    Helliwell PS
    Reumatismo; 2007; 59 Suppl 1():61-3. PubMed ID: 17828347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for rheumatoid and psoriatic arthritis.
    Verheul MK; Fearon U; Trouw LA; Veale DJ
    Clin Immunol; 2015 Nov; 161(1):2-10. PubMed ID: 25934385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the recurrence risk of arthritis among psoriatic patients.
    Pedersen OB; Junker P
    Scand J Rheumatol; 2009; 38(4):321-2. PubMed ID: 19308804
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA markers and progression in psoriatic arthritis.
    Gladman DD; Farewell VT; Kopciuk KA; Cook RJ
    J Rheumatol; 1998 Apr; 25(4):730-3. PubMed ID: 9558177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen alleles and susceptibility to psoriatic arthritis.
    Chandran V; Bull SB; Pellett FJ; Ayearst R; Rahman P; Gladman DD
    Hum Immunol; 2013 Oct; 74(10):1333-8. PubMed ID: 23916976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriatic arthritis: prevalence, diagnosis, and review of therapy for the dermatologist.
    Ruderman EM; Tambar S
    Dermatol Clin; 2004 Oct; 22(4):477-86, x. PubMed ID: 15450343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project.
    FitzGerald O; Mease PJ; Helliwell PS; Chandran V
    J Rheumatol; 2014 Jun; 41(6):1244-8. PubMed ID: 24882863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression analysis of multivariate panel count data.
    He X; Tong X; Sun J; Cook RJ
    Biostatistics; 2008 Apr; 9(2):234-48. PubMed ID: 17626224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of psoriatic arthritis.
    Gladman DD
    Baillieres Clin Rheumatol; 1994 May; 8(2):379-94. PubMed ID: 8076393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis.
    Kumar R; Sharma A; Dogra S
    Indian J Dermatol Venereol Leprol; 2014; 80(1):15-23. PubMed ID: 24448118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of disease activity measures for psoriatic arthritis: what is the best approach?
    Her M; Kavanaugh A
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
    Gladman DD; Antoni C; Mease P; Clegg DO; Nash P
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii14-7. PubMed ID: 15708927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of psoriatic arthritis in Italian psoriatic patients.
    Salvarani C; Lo Scocco G; Macchioni P; Cremonesi T; Rossi F; Mantovani W; Battistel B; Bisighini G; Portioli I
    J Rheumatol; 1995 Aug; 22(8):1499-503. PubMed ID: 7473473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.